Search

So what exactly are you looking for? Let us know and we will help you find the best answer

Clear All

Glenmark Pharmaceuticals Ltd.

  • NSE: GLENMARK

  • BSE: 532296

  • Q
  • V
  • T
  • Strong Performer, Getting Expensive
67.40/100

Quality Score

High Financial Strength
34.33/100

Valuation Score

Mid Valuation
76.17/100

Technical Score

Technically Bullish
Broker Average Rating

4.00

Broker Average Rating

MFI

56.67

MFI is mid-range

50Day SMA Rs

459.65 Rs

Price above SMA 459.65

Quality score

67.40

High Financial Strength

30Day SMA Rs

480.13 Rs

Price above SMA 480.13

Broker Covering stock

7.00

7 Broker Covering stock

Broker 6M Target upgrade

7.00

7 Broker 6M Target upgrade

Broker 6M Target downgrade

1.00

1 Broker 6M Target downgrade

Momentum score

76.17

Technically Bullish

Price to Book Ratio

2.56

Above industry Median

Broker Reports in 1Yr

15.00

15 Broker Reports in 1Yr

TTM PE Ratio

15.60

Below industry Median

Broker 6M Reco upgrade

2.00

2 Broker 6M Reco upgrade

RSI

57.86

RSI is mid-range

Net Profit Qtr Cr

254.04 Cr

High in industry

Operating Revenues Qtr Cr

2344.79 Cr

High in industry

MACD

7.08

MACD above Signal and Center

Valuation score

34.33

Mid Valuation

MACD Signal Line

6.76

MACD above Signal and Center

FII holding holding %

23.40 %

FII holding decreased by 5.11%.

Promoter holding holding %

46.62 %

No change in Promoter holding

MF holding holding %

2.36 %

MF holding decreased by 1.38%.

Broker 6M Reco downgrade

1.00

1 Broker 6M Reco downgrade

100Day SMA Rs

423.52 Rs

Price above SMA 423.52

Institutions holding holding %

28.93 %

Institutions holding decreased by 6.32%.

200Day SMA Rs

363.97 Rs

Price above SMA 363.97

NSE GLENMARK
507.95
  • 492.70 Close
  • 495.05 Open
  • 93.95 Lk Volume
Today Low/High
Low 495.05
High 518.45
52 Week Low/High
13-03-2020 161.65
22-06-2020 573.05

Peer Comparison

All values except ratios in INR(Crores)

Stock Name Current Price Rs PE TTM Price To Earnings Market Capitalization In Cr Dividend Yield 1yr % Net Profit Qtr Cr Net Profit Annual Growth YoY % Operating Revenues Qtr Cr Revenue Growth Qtr YoY Price To Book Value
Glenmark Pharmaceuticals Ltd. 508.9 15.59 14359.63 0.88 254.04 0 2344.78 0.94 2.56
Sun Pharmaceutical Industries Ltd. 523.35 491.26 125567.36 0.76 -2429.81 0 7585.25 -9.43 2.55
Divi's Laboratories Ltd. 3344.4 55.61 88777.09 0.47 492.06 0 1730.47 48.8 12.14
Dr. Reddy's Laboratories Ltd. 5333.35 46.73 88640.27 0.46 586.9 0 4426.5 14.72 5.68
Cipla Ltd. 806.25 39.44 65003.9 0.49 571.42 0 4346.16 8.95 4.04
Lupin Ltd. 1085.9 -105.29 49202.12 0.55 108.14 0 3527.86 -20.16 3.91
Torrent Pharmaceuticals Ltd. 2876.3 43.07 48678.5 1.11 321 0 2056 1.68 10.09
Aurobindo Pharma Ltd. 828.1 16.13 48518.37 0.51 792.68 0 5924.78 8.81 2.88